Real-world Evidence Solutions Market Report 2022-2029 : Incorporation of Artificial Intelligence (AI) in the RWE Industry Presents Lucrative Growth Opportunities

News provided by

Aug 03, 2022, 06:15 ET

DUBLIN, Aug. 3, 2022 /PRNewswire/ -- The "Real-world Evidence Solutions Market by Component, Application, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The RWE solutions market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.9 billion by 2029

Rapidly growing big data in healthcare, shift from volume to value-based care, and rising focus towards personalized healthcare are the key factors driving the growth of the global RWE solutions market. Further, significant growth opportunities for existing market players and new entrants are provided by emerging markets, rising focus on end-to-end RWE services, and the rising adoption of wearable devices and AI in RWE.

An in-depth analysis of the geographical scenario of the RWE solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global RWE solutions market in 2022, followed by Asia-Pacific and Europe. However, Asia-Pacific is slated to register the fastest growth rate. The growth of this regional market is driven by the growing demand for data defining the value and effectiveness of medicines, the increasing need for conducting real-world studies in drug R&D, and the rising government initiatives for promoting the use of real-world studies for regulatory decision-making.

Scope of the Report
Global RWE Solutions Market, by Component

Datasets
Disparate Datasets
EMR/EHR/Clinical Data
Claims & Billing Data
Pharmacy Data
Product/Disease Registries Data
Other Disparate Datasets
Integrated Datasets
Consulting & Analytics

Global RWE Solutions Market, by Application

Market Access & Reimbursement/Coverage Decisions
Drug Development & Approvals
Oncology
Neurology
Immunology
Cardiovascular Diseases
Other Therapeutic Areas
Post Market Surveillance
Medical Device Development & Approvals
Other Applications

Global RWE Solutions Market, by End User

Pharmaceutical, Biotechnology, and Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users

Global RWE Solutions Market, by Geography

Market Dynamics

Drivers

Rising Focus on Personalized Healthcare
Delays in Drug Development and the Consequent Increase in Development Costs
Growing Incidence of Chronic Diseases
Shift Toward Value-based Care
Rapidly Growing Big Data in the Healthcare Sector

Restraints

Reluctance to Rely on Real-World Studies

Opportunities

Emerging Economies
Rising Focus on end-to-end RWE Services

Challenges

Lack of Standardized Methodologies for Developing RWE

Trends

The Incorporation of Artificial Intelligence (AI) in the RWE Industry
The Adoption of AI Technologies is Growing in the Following Areas:

Clinical Trials Design
Modeling and Forecasting Patient Enrichment & Recruitment
Selecting Investigator Site
Patient Monitoring & Managing and Medication Adherence & Retention
AI-enabled Clinical Trial Analytics
Outsourcing Essential AI Solutions Via Strategic Partnerships & Collaborations
Market Access Using AI Solutions
Post-market Surveillance Using AI Solutions

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Real-world Evidence (RWE) Solutions Market: Regulatory Analysis

6. Pricing Models (Emr/Genomic/Integrated Datasets)

7. Real-world Evidence Solutions Market, by Component

8. Real-world Evidence Solutions Market, by Application

9. Real-world Evidence Solutions Market, by End User

10. Real-world Evidence Solutions Market, by Geography

11. Competitive Landscape

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

13. Appendix

Companies Mentioned